EcoDrugPlus

Alpha-2b Adrenergic Receptor

Ensembl ID : ENSTRUG00000020960
Gene Symbol: LOC101079400
4 Cross references
174 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSTRUG00000017882
Gene Symbol: AOC1
4 Cross references
231 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSTRUG00000010470
Gene Symbol: APP
4 Cross references
203 Possible Orthologues:

Amyloid-Beta A4 Protein

Ensembl ID : ENSTRUG00000010922
Gene Symbol: LOC101078447
4 Cross references
205 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSTRUG00000012421
Gene Symbol: AR
3 Cross references
213 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSTRUG00000005373
Gene Symbol: LOC101067852
2 Cross references
206 Possible Orthologues:

Angiotensin Ii Receptor Type 1

Ensembl ID : ENSTRUG00000017757
Gene Symbol: AGTR1
3 Cross references
198 Possible Orthologues:

Anti-Apoptotic Protein Nr13

Ensembl ID : ENSTRUG00000025217
Gene Symbol: LOC101075023
4 Cross references
128 Possible Orthologues:

Apelin Receptor 2

Ensembl ID : ENSTRUG00000016544
Gene Symbol: APLNR2
1 Cross references
171 Possible Orthologues:

Apurinic/apyrimidinic Endodeoxyribonuclease 1

Ensembl ID : ENSTRUG00000004268
Gene Symbol: APEX1
3 Cross references
212 Possible Orthologues:

Arachidonate 12-Lipoxygenase

Ensembl ID : ENSTRUG00000005975
Gene Symbol: ALOX12
1 Cross references
200 Possible Orthologues:

Arachidonate 5-Lipoxygenase A

Ensembl ID : ENSTRUG00000002647
Gene Symbol: ALOX5A
1 Cross references
225 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).